Abstract:The integrin β6 (ITGB6) gene, which encodes the limiting subunit of the integrin αvβ6 heterodimer, plays an important role in wound healing and carcinogenesis. The mechanism underlying ITGB6 regulation, including the identification of DNA elements and cognate transcription factors responsible for basic transcription of human ITGB6 gene, remains unknown. This report describes the cloning and characterization of the human ITGB6 promoter. Using 5′-RACE (rapid amplification of cDNA ends) analysis, the transcriptio… Show more
“…Integrins can be composed from 1 of 18 α-and 8 β-subunits to form 24 known heterodimer combinations ( Fig. 1a) [1,2]. Integrin subunits range from between 750 and 1000 amino acid residues in length and are constructed from several domains that are flanked by flexible linker regions, a membrane-spanning helix and a typically short, unstructured cytoplasmic tail (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Each α/β combination confers a particular binding specificity and consequential downstream signalling capabilities which underpin the structural and functional diversity of the integrin family (Fig. 1a) [1]. For example, heterodimers such as α5β1, αVβ3, αVβ5 and αVβ6 mediate cellular adhesion by binding to Arg-Gly-Asp (RGD) sequence motifs found within a number of abundant ECM proteins, such as fibronectin, vitronectin, fibrinogen and von Fig.…”
Section: Introductionmentioning
confidence: 99%
“…As such, an exciting development in β6 research has been the recent identification by Xu et al of the previously unknown DNA elements and cognate transcription factors responsible for transcription of the β6 coding sequence (ITGB6, Fig. 3) [1].…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, Xu et al determined that mutation of the cMyb and AP1-binding sites did not exert significant effects on promoter activity [1]. They employed 5′-rapid amplification of cDNA ends (5′-RACE) to determine that the transcriptional Fig.…”
Section: Introductionmentioning
confidence: 99%
“…They employed 5′-rapid amplification of cDNA ends (5′-RACE) to determine that the transcriptional Fig. 2 Duke's and Tumour-Node-Metastasis staging systems with respective survival data from the European Society for Medical Oncology [72] start site was located 204 bp upstream of the ATG translation initiation site [1]. They then investigated the β6 promoter by cloning a series of truncated 5′-deletion fragments within the 5′-flanking region of the ITGB6 coding sequence into pGL2-Basic promoter-deficient luciferase reporter vectors [1].…”
The β6 subunit of the αvβ6 integrin heterodimer has long been an enigma in cancer biology though recent research has provided many new insights into its biology. Collectively, these findings include discovery of the transcriptional, translational and cell biological mechanisms by which β6 acts, the identification of the cellular influences β6 exerts upon the cell proteome, the characterisation of multiple β6-centric pro-metastatic signalling systems and the search for pharmacological therapies (industry and academia) targeted against β6. Once expressional restriction is overcome in early colorectal cancer (CRC), epithelial cell surface restricted αvβ6 can physically interact with, and activate, known oncoproteins, and has the potential to enable the cross-talk through non-canonical signal transduction pathways, resulting in the adoption of an invasive/metastatic phenotype. This recent research has identified numerous interconnections and potential feedback loops, highlighting the fact that the expression of the β6 subunit may initiate a cascade of downstream effects on the CRC cell rather than acting through a single mechanism. We here review these recent studies and postulate that the existence of a cell surface uPAR/αvβ6/TGFβ "metastasome" interactome in/on a proportion of colorectal cancer cells, where β6 expression sequesters and activates multiple systems at the invasive front of tumour lesions, promoting cancer metastasis and hence explaining why β6 has been correlated with reduced patient survival in CRC.
“…Integrins can be composed from 1 of 18 α-and 8 β-subunits to form 24 known heterodimer combinations ( Fig. 1a) [1,2]. Integrin subunits range from between 750 and 1000 amino acid residues in length and are constructed from several domains that are flanked by flexible linker regions, a membrane-spanning helix and a typically short, unstructured cytoplasmic tail (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Each α/β combination confers a particular binding specificity and consequential downstream signalling capabilities which underpin the structural and functional diversity of the integrin family (Fig. 1a) [1]. For example, heterodimers such as α5β1, αVβ3, αVβ5 and αVβ6 mediate cellular adhesion by binding to Arg-Gly-Asp (RGD) sequence motifs found within a number of abundant ECM proteins, such as fibronectin, vitronectin, fibrinogen and von Fig.…”
Section: Introductionmentioning
confidence: 99%
“…As such, an exciting development in β6 research has been the recent identification by Xu et al of the previously unknown DNA elements and cognate transcription factors responsible for transcription of the β6 coding sequence (ITGB6, Fig. 3) [1].…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, Xu et al determined that mutation of the cMyb and AP1-binding sites did not exert significant effects on promoter activity [1]. They employed 5′-rapid amplification of cDNA ends (5′-RACE) to determine that the transcriptional Fig.…”
Section: Introductionmentioning
confidence: 99%
“…They employed 5′-rapid amplification of cDNA ends (5′-RACE) to determine that the transcriptional Fig. 2 Duke's and Tumour-Node-Metastasis staging systems with respective survival data from the European Society for Medical Oncology [72] start site was located 204 bp upstream of the ATG translation initiation site [1]. They then investigated the β6 promoter by cloning a series of truncated 5′-deletion fragments within the 5′-flanking region of the ITGB6 coding sequence into pGL2-Basic promoter-deficient luciferase reporter vectors [1].…”
The β6 subunit of the αvβ6 integrin heterodimer has long been an enigma in cancer biology though recent research has provided many new insights into its biology. Collectively, these findings include discovery of the transcriptional, translational and cell biological mechanisms by which β6 acts, the identification of the cellular influences β6 exerts upon the cell proteome, the characterisation of multiple β6-centric pro-metastatic signalling systems and the search for pharmacological therapies (industry and academia) targeted against β6. Once expressional restriction is overcome in early colorectal cancer (CRC), epithelial cell surface restricted αvβ6 can physically interact with, and activate, known oncoproteins, and has the potential to enable the cross-talk through non-canonical signal transduction pathways, resulting in the adoption of an invasive/metastatic phenotype. This recent research has identified numerous interconnections and potential feedback loops, highlighting the fact that the expression of the β6 subunit may initiate a cascade of downstream effects on the CRC cell rather than acting through a single mechanism. We here review these recent studies and postulate that the existence of a cell surface uPAR/αvβ6/TGFβ "metastasome" interactome in/on a proportion of colorectal cancer cells, where β6 expression sequesters and activates multiple systems at the invasive front of tumour lesions, promoting cancer metastasis and hence explaining why β6 has been correlated with reduced patient survival in CRC.
Overexpression of integrin αvβ6 is believed to play an important role in the invasion and metastasis of oral squamous cell carcinoma (OSCC). However, little is known about the molecular mechanisms leading to αvβ6 upregulation in OSCC. As the integrin β6 (ITGB6) is the only partner with αv, the expression of αvβ6 is dependent on ITGB6, it is, therefore, pivotal to investigate the mechanisms underlying ITGB6 overexpression in OSCC. We previously reported the cloning and characterization of human ITGB6 gene. In the current study, we further investigated the molecular mechanisms of ITGB6 expression and the upregulation by carcinogenesis related cytokine-transforming growth factor-β1 (TGF-β1) in OSCC cells. We first demonstrated that TGF-β1 can induce ITGB6 mRNA and protein express in a time and concentration dependent manner, and the induced-ITGB6 mRNA was not due to increase the mRNA stability, but regulated at transcriptional level. By using a luciferase reporter assay, site-mutation, RNA interference, and chromatin immunoprecipitation assay, we revealed for the first time that JunB, a member of the activator protein-1 (AP-1) family, is involved in the positive regulation to the ITGB6 transcription induced by TGF-β1 in OSCC cells. Furthermore, our data also demonstrated that histone acetyltransferase (HAT) CBP mediated histone H3 and H4 hyperacetylation, and RNA Polymerase II recruitment to ITGB6 promoter, facilitated the binding of transcription factor JunB to ITGB6 promoter after TGF-β1 stimulation. Collectively, these findings demonstrate that JunB and CBP-mediated histone hyperacetylation are responsible for TGF-β1 induced ITGB6 transcription in OSCC cells, suggesting that epigenetic mechanisms are responsible for the active transcription expression of ITGB6 induced by TGF-β1 in OSCC cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.